NCT06790368

Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

Prospective Clinical Follow-up to Evaluate the Safety of Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 80 (estimated)
• Sponsor: Inmunotek S.L. · Industry
• Sex: All
• Age: 14 Years
• Healthy volunteers: —

Summary

Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings. This study will be conducted in Spain (multicentric), multicentric and data will be collected prospectively.

Detailed description

Observational, multicentric (Spain), prospective study and data will be collected properly. The total number of participants is expected to be 80. The patients aged equal or more than 14 years old, sentitized to himenoptera venom, not gender differentiation.

Conditions

• Allergy, Insect Venom
• Allergy Insect Stinging
• Insect Sting Allergy

Interventions

Type	Name	Description
BIOLOGICAL	VENOX	Treatment with allergy vaccine against Vespula spp. (wasp) or Apis mellifera (bee), as per clinical indication.

Timeline

• Start date: 2025-01-01
• Primary completion: 2026-03-01
• Completion: 2026-06-01
• First posted: 2025-01-24
• Last updated: 2025-05-01

Locations

3 sites across 1 country: Spain